scispace - formally typeset
L

Leah C. Byrne

Researcher at University of Pittsburgh

Publications -  46
Citations -  1885

Leah C. Byrne is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Gene delivery & Retinal. The author has an hindex of 12, co-authored 41 publications receiving 1437 citations. Previous affiliations of Leah C. Byrne include Helen Wills Neuroscience Institute & University of Pennsylvania.

Papers
More filters
Journal ArticleDOI

In Vivo???Directed Evolution of a New Adeno-Associated Virus for Therapeutic Outer Retinal Gene Delivery from the Vitreous

TL;DR: It is shown that delivery of a new vector into the eye’s easily accessible vitreous humour transduces the entire retina and rescues degenerative eye disease phenotypes, suggesting that gene therapy vectors can be designed to penetrate dense tissues, which currently constitute barriers to gene delivery.
Journal ArticleDOI

Rod-derived cone viability factor promotes cone survival by stimulating aerobic glycolysis.

TL;DR: It is shown that RdCVF acts through binding to Basigin-1 (BSG1), a transmembrane protein expressed specifically by photoreceptors, resulting in increased glucose entry into cones, and an entirely novel mechanism of neuroprotection through the stimulation of glucose metabolism.
Journal ArticleDOI

Viral-mediated RdCVF and RdCVFL expression protects cone and rod photoreceptors in retinal degeneration

TL;DR: Results indicate different functions for Nxnl1 isoforms in the retina and suggest that RdCVF gene therapy has potential for treating retinal degenerative disease.
Journal ArticleDOI

In vivo genome editing improves motor function and extends survival in a mouse model of ALS

TL;DR: The potential for CRISPR-Cas9 to treat SOD1-linked forms of ALS and other central nervous system disorders caused by autosomal dominant mutations is illustrated.
Journal ArticleDOI

Massively parallel cis-regulatory analysis in the mammalian central nervous system

TL;DR: This work adapts exome capture technology to instead capture candidate CREs, thereby tiling across the targeted regions and markedly increasing the length of CREs that can be readily assayed, and packages the library into adeno-associated virus (AAV), thereby allowing delivery to target organs in vivo.